Pretreatment Group Consultation for Patients With Colorectal Cancer

Completed

• Conditions: Colorectal Neoplasm
• Interventions: Other: Pretreatment group consultation

• Registration Number: NCT03888313
• Lead Sponsor: Sahlgrenska University Hospital, Sweden

Brief Summary

An explorative study of the patients' experience of participating at a group consultation, together with other patients with newly diagnosed colon or rectal cancer

Detailed Description

The group consultation is planned to be on the Friday of the same week as the patient recieved a suggested treatment plan i.e. after MDT, at a personal consultation with his/her colorectal surgeon. During the group consultation the steps necessary for the patient to take responsability for in connection with the operation. Ample time for questions, clarifications and discussions. Appropriate clinical trials are presented

Study Timeline

• Study First Submitted: 2019-03-16
• Study First Submitted QC: 2019-03-22
• Study First Posted: 2019-03-25
• Study Start: 2019-04-26
• Primary Completion: 2019-11-30
• Status Verified: 2021-01
• Study Completion: 2021-01-13
• Last Update Submitted: 2021-09-23
• Last Update Posted: 2021-09-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 161

Inclusion Criteria

• Patients participating in the pretreatment group consultation

Exclusion Criteria

• Not able to answer questionnaire

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients participating in the pretreatment group consultation	Pretreatment group consultation	Patients who chosse to participate in a group consultation (with other patients also in the process of undergoing surgery for colorectal cancer).

Primary Outcome Measures

Name	Time	Method
The patient's experience of participating in a pretreatment group consultation	Before start of treatment	A questionnaire with questions on the patient's experience of the information received and their experience of participating in the pretreatment group consultation will be used to collect descriptive data. Some of the questions have been developed through semi-structured interviews with patients with colon or rectal cancer other are standardized questionnaires used in other studies.; The questionnaire includes questions on which information resources the patients have used (such as social media, patient organizations).Their experience of the pretreatment group consultation will be assessed by "Would you recommend someone in the same situation as you to attend the pretreatment group consultation?". Possible answering options are "Yes", "No" and "Don't know". The EuroQol's EQ-5D-5L for assessment of health related quality of will be included mainly as a tool for assurance of external validity, and not as an outcome measure. Both the indices and the VAS-scale may be used.

Trial Locations

Locations (1)

Sahlgrenska University Hospital/Östra; 🇸🇪 Gothenburg, Västra Götaland Region, Sweden